TrialJournal of translational medicine2022

A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease.

Yvelise Ferro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.